Anesthetics and brain protection

Current Opinion in Anaesthesiology

Volumn 20, Issue 5, 2007, Pages 395-399

  Head, Brian P ^a   Patel, Piyush ^a,b  

^a University of California   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anesthetics; Cerebral ischemia; Neurogenesis

Indexed keywords

ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; DESFLURANE; DEXMEDETOMIDINE; ETOMIDATE; INHALATION ANESTHETIC AGENT; ISOFLURANE; LIDOCAINE; PROPOFOL; SEVOFLURANE; XENON;

BRAIN ISCHEMIA; BRAIN PROTECTION; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; REVIEW;

ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ANESTHETICS, LOCAL; BRAIN; BRAIN ISCHEMIA; HUMANS; NEUROPROTECTIVE AGENTS; TIME FACTORS;

EID: 34548676161     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3282efa69d     Document Type: Review

References (50)

1. Kitano H, Kirsch JR, Hurn PD, et al. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab 2007; 27:1108-1128. This is an excellent and thorough review of anesthetic neuroprotection.
2. Clarkson AN. Anesthetic-mediated protection/preconditioning during cerebral ischemia. Life Sci 2007; 80:1157-1175. This is an excellent and thorough review of anesthetic neuroprotection.
3. Todd MM, Chadwick HS, Shapiro HM, et al. The neurologic effects of thiopental therapy following experimental cardiac arrest in cats. Anesthesiology 1982; 57:76.
4. Warner DS, Zhou J, Ramani R, et al. Reversible focal ischemia in the rat: Effects of halothane, isoflurane, and methohexital anesthesia. J Cereb Blood Flow Metab 1991; 11:794-802.
5. Drummond JC. Do barbiturates really protect the brain? Anesthesiology 1993; 78:611-613.
6. Warner DS, Takaoka S, Wu B, et al. Electroencephalographic burst suppression is not required to elicit maximal neuroprotection from pentobarbital in a rat model of focal cerebral ischemia. Anesthesiology 1996; 84:1475-1484.
7. Baughman VL, Hoffman WE, Thomas C, et al. Comparison of methohexital and isoflurane on neurologic outcome and histopathology following incomplete ischemia in rats. Anesthesiology 1990; 72:85-94.
8. Soonthan-Brant V, Patel PM, Drummond JC, et al. Fentanyl does not increase brain injury after focal cerebral ischemia in rats. Anesth Analg 1999; 88:49-55.
9. Nellgard B, Mackensen GB, Pineda J, et al. Anesthetic effects on cerebral metabolic rate predict histologic outcome from near-complete forebrain ischemia in the rat. Anesthesiology 2000; 93:431-436.
10. Warner DS, McFarlane C, Todd MM, et al. Sevoflurane and halothane reduce focal ischemic brain damage in the rat. Anesthesiology 1993; 79:985-992.
11. Werner C, Mollenberg O, Kochs E, et al. Sevoflurane improves neurological outcome after incomplete cerebral ischaemia in rats. Br J Anaesth 1995; 75:756-760.
12. Engelhard K, Werner C, Reeker W, et al. Desflurane and isoflurane improve neurological outcome after incomplete cerebral ischaemia in rats. Br J Anaesth 1999; 83:415-421.
13. Haelewyn B, Yvon A, Hanouz JL, et al. Desflurane affords greater protection than halothane against focal cerebral ischaemia in the rat. Br J Anaesth 2003; 91:390-396.
14. Du C, Hu R, Csernansky C, et al. Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis? J Cereb Blood Flow Metab 1996; 16:195-201.
15. Kawaguchi M, Kimbro JR, Drummond JC, et al. Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology 2000; 92:1335-1342.
16. Inoue S, Davis DP, Drummond JC, et al. The combination of isoflurane and caspase 8 inhibition results in sustained neuroprotection in rats subject to focal cerebral ischemia. Anesth Analg 2006; 102:1548-1555.
17. Inoue S, Drummond JC, Davis DP, et al. Combination of isoflurane and caspase inhibition reduces cerebral injury in rats subjected to focal cerebral ischemia. Anesthesiology 2004; 101:75-81.
18. Engelhard K, Werner C, Eberspacher E, et al. Sevoflurane and propofol influence the expression of apoptosis-regulating proteins after cerebral ischaemia and reperfusion in rats. Eur J Anaesthesiol 2004; 21:530-537.
19. Sakai H, Sheng H, Yates RB, et al. Isoflurane provides long-term protection against focal cerebral ischemia in the rat. Anesthesiology 2007; 106:92-99. This excellent study demonstrates that long-term protection with isoflurane anesthesia is achievable. The study details the conditions necessary for achievement of duration protection.
20. Gelb AW, Bayona NA, Wilson JX, et al. Propofol anesthesia compared to awake reduces infarct size in rats. Anesthesiology 2002; 96:1183-1190.
21. Pittman JE, Sheng H, Pearlstein RD, et al. Comparison of the effects of propofol and pentobarbital on neurologic outcome and cerebral infarction size after temporary focal ischemia in the rat. Anesthesiology 1997; 87:1139-1144.
22. Bayona NA, Gelb AW, Jiang Z, et al. Propofol neuroprotection in cerebral ischemia and its effects on low-molecular-weight antioxidants and skilled motor tasks. Anesthesiology 2004; 100:1151-1159.
23. Drummond JC, McKay LD, Cole DJ, et al. The role of nitric oxide synthase inhibition in the adverse effects of etomidate in the setting of focal cerebral ischemia in rats. Anesth Analg 2005; 100:841-846.
24. Hoffman WE, Charbel FT, Edelman G, et al. Comparison of the effect of etomidate and desflurane on brain tissue gases and pH during prolonged middle cerebral artery occlusion. Anesthesiology 1998; 88:1188-1194.
25. Seyfried FJ, Adachi N, Arai T. Suppression of energy requirement by lidocaine in the ischemic mouse brain. J Neurosurg Anesthesiol 2005; 17:75-81.
26. Shokunbi MT, Gelb AW, Wu XM, et al. Continuous lidocaine infusion and focal feline cerebral ischemia. Stroke 1990; 21:107-111.
27. Lei B, Popp S, Capuano-Waters C, et al. Lidocaine attenuates apoptosis in the ischemic penumbra and reduces infarct size after transient focal cerebral ischemia in rats. Neuroscience 2004; 125:691-701.
28. Franks NP, Dickinson R, de Sousa SL, et al. How does xenon produce anaesthesia? Nature 1998; 396:324.
29. Wilhelm S, Ma D, Maze M, et al. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 2002; 96:1485-1491.
30. Homi HM, Yokoo N, Ma D, et al. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 2003; 99:876-881.
31. Dingley J, Tooley J, Porter H, et al. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 2006; 37:501-506.
32. Ma D, Hossain M, Chow A, et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005; 58:182-193.
33. Rajakumaraswamy N, Ma D, Hossain M, et al. Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models. Neurosci Lett 2006; 409:128-133.
34. Ma D, Hossain M, Pettet GK, et al. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab 2006; 26:199-208.
35. Patel PM, Drummond JC, Goskowicz R, et al. The volatile anesthetic isoflurane reduces ischemia induced release of glutamate in rats. J Cereb Blood Flow Metab 1993; 13:S685.
36. Harada H, Drummond JC, Cole DJ, et al. Isoflurane reduces NMDA toxicity in vivo in the rat cerebral cortex. Anesth Analg 1999; 89:1442-1447.
37. Bickler PE, Warner DS, Stratmann G, et al. gamma-Aminobutyric acid-A receptors contribute to isoflurane neuroprotection in organotypic hippocampal cultures. Anesth Analg 2003; 97:564-571.
38. Payne RS, Akca O, Roewer N, et al. Sevoflurane-induced preconditioning protects against cerebral ischemic neuronal damage in rats. Brain Res 2005; 1034:147-152.
39. Xiong L, Zheng Y, Wu M, et al. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 2003; 96:233-237.
40. Zheng S, Zuo Z. Isoflurane preconditioning reduces purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience 2003; 118:99-106.
41. Bickler PE, Fahlman CS. The inhaled anesthetic, isoflurane, enhances Ca2+-dependent survival signaling in cortical neurons and modulates MAP kinases, apoptosis proteins and transcription factors during hypoxia. Anesth Analg 2006; 103:419-429. This is a detailed description of the signal transduction pathways that are activated by exposure to isoflurane anesthesia.
42. Bickler PE, Zhan X, Fahlman CS. Isoflurane preconditions hippocampal neurons against oxygen-glucose deprivation: role of intracellular Ca2+ and mitogen-activated protein kinase signaling. Anesthesiology 2005; 103:532-539.
43. Kitano H, Young JM, Cheng J, et al. Gender-specific response to isoflurane preconditioning in focal cerebral ischemia. J Cereb Blood Flow Metab 2007; 27:1377-1386.
44. Patel AJ, Honore E. Anesthetic-sensitive 2P domain K+ channels. Anesthesiology 2001; 95:1013-1021.
45. Heurteaux C, Guy N, Laigle C, et al. TREK-1, a K+ channel involved in neuroprotection and general anesthesia. Embo J 2004; 23:2684-2695.
46. Franks NP, Honore E. The TREK K2P channels and their role in general anaesthesia and neuroprotection. Trends Pharmacol Sci 2004; 25:601-608.
47. Kluska MM, Witte OW, Bolz J, et al. Neurogenesis in the adult dentate gyrus after cortical infarcts: effects of infarct location, N-methyl-D-aspartate receptor blockade and anti-inflammatory treatment. Neuroscience 2005; 135:723-735.
48. Brinton RD, Wang JM. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent. Curr Alzheimer Res 2006; 3:185-190.
49. Xilouri M, Avlonitis N, Calogeropoulou T, et al. Neuroprotective effects of steroid analogues on P19-N neurons. Neurochem Int 2007; 50:660-670.
50. Engelhard K, Winkelheide U, Werner C, et al. Sevoflurane affects neurogenesis after forebrain ischemia in rats. Anesth Analg 2007; 104:898-903. This was one of the first studies to evaluate the effect of anesthetics on neurogenesis after ischemia. The authors showthat the volatile agent sevoflurane not only protects neurons against ischemic injury but also accelerates post-ischemic neurogenesis.